Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial
NCT ID: NCT02140866
Last Updated: 2017-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
55 participants
INTERVENTIONAL
2014-05-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hand Exercise
The intervention group will receive an exercise program for the hand/arm in combination with a compensatory intervention program (CIP).
Hand Exercise
Compensatory Intervention Program (CIP)
The control group will receive the Compensatory Intervention Program (CIP) only.
Compensatory Intervention Program (CIP)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hand Exercise
Compensatory Intervention Program (CIP)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18.
* Diagnosis of rheumatoid arthritis (2).
* Involvement of the hands, due to minimum one tender wrist, metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joint in one of the hands.
* Be on stable medication for at least 3 months prior to participation.
* Self-reported decreased ability to perform personal and instrumental ADL tasks involving the hands.
Exclusion Criteria
* Hand surgery within 6 months of study participation
* Other pain condition involving muscles and/or joints, e.g. fibromyalgia.
* Prednisolon therapy, change in dose of biological agent or start of treatment with a new biological agent within the last 3 month before study start.
* Inability to understand the information or to speak Danish
* Any other condition that in the opinion of the investigator or accessing rheumatologist puts an otherwise eligible participant at increased risk by participation or otherwise make the person unfit for participation.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oak Foundation
OTHER
Aase and Ejnar Danielsens Foundation
OTHER
Danish Physiotherapy Foundation
UNKNOWN
The Danish Rheumatism Association
OTHER
Danish Association of Occupational Therapist
OTHER
Parker Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva Ejlersen Wæhrens
Senior researcher, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva E Wæhrens, PhD
Role: PRINCIPAL_INVESTIGATOR
The Parker Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen University Hospital, Frederiksberg
Frederiksberg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ellegaard K, von Bulow C, Ropke A, Bartholdy C, Hansen IS, Rifbjerg-Madsen S, Henriksen M, Waehrens EE. Hand exercise for women with rheumatoid arthritis and decreased hand function: an exploratory randomized controlled trial. Arthritis Res Ther. 2019 Jun 26;21(1):158. doi: 10.1186/s13075-019-1924-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
109
Identifier Type: -
Identifier Source: org_study_id